Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 2495847)

Published in Crit Care Clin on April 01, 1989

Authors

R A Petrak1, R A Balk, R C Bone

Author Affiliations

1: Department of Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.

Articles by these authors

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest (1992) 47.46

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA (2001) 5.86

Is it time to pull the pulmonary artery catheter? JAMA (1996) 5.69

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med (1993) 5.46

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med (1996) 5.25

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA (1994) 5.24

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86

The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med (1987) 3.89

Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1989) 3.41

The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome. N Engl J Med (1998) 3.40

Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1992) 2.99

Sepsis: a new hypothesis for pathogenesis of the disease process. Chest (1997) 2.84

Definitions for sepsis and organ failure. Crit Care Med (1992) 2.69

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med (1994) 2.66

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med (1995) 2.48

Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med (1991) 2.28

E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. JAMA (2000) 2.07

Honoring patient preferences and rationing intensive care. Are these compatible goals? Arch Intern Med (1991) 2.03

Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med (1996) 1.89

T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med (1999) 1.76

Primary Sjogren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum (1984) 1.75

Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA (1994) 1.64

Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med (1993) 1.61

The noninvasive respiratory care unit. Patterns of use and financial implications. Chest (1991) 1.56

Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group. Chest (1990) 1.55

Medical effectiveness of esophageal balloon pressure manometry in weaning patients from mechanical ventilation. Crit Care Med (1995) 1.43

Sleep apnea and the Arnold-Chiari malformation. Am Rev Respir Dis (1985) 1.42

A word of caution regarding a new long-acting bronchodilator. JAMA (1994) 1.41

Prognostic factors in sepsis: the cold facts. Crit Care Med (1992) 1.40

A piece of my mind. Lemonade: the last refreshing taste. JAMA (1996) 1.39

Selective digestive decontamination in critically ill patients. Crit Care Med (1993) 1.39

Intracavitary amphotereicin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med (1980) 1.33

Sepsis, sepsis syndrome, and the systemic inflammatory response syndrome (SIRS). Gulliver in Laputa. JAMA (1995) 1.32

Intravascular coagulation associated with the adult respiratory distress syndrome. Am J Med (1976) 1.26

Evaluation and correction of dysphagia-producing cervical osteophytosis. Laryngoscope (1974) 1.20

An experiment in medical education. A critical analysis using traditional criteria. JAMA (1991) 1.14

Controlled oxygen administration in acute respiratory failure in chronic obstructive pulmonary disease: a reappraisal. Am J Med (1978) 1.13

Quantitative deposition of ultrafine stable particles in the human respiratory tract. J Appl Physiol (1985) (1985) 1.11

Ibuprofen in canine endotoxin shock. J Clin Invest (1982) 1.10

Measurements of medicine. Crit Care Med (1995) 1.10

The bottom line in asthma management is patient education. Am J Med (1993) 1.08

Neural phase-locking properties in the absence of cochlear outer hair cells. Hear Res (1981) 1.07

Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch Intern Med (1997) 1.06

High-tech predicament: pulmonary artery catheter. JAMA (1990) 1.05

Acoustic characteristics of speech following uvulopalatopharyngoplasty. Laryngoscope (1989) 1.03

Pneumothorax detection using computerised analysis of breath sounds. Med Biol Eng Comput (2002) 1.03

Pneumothorax detection using pulmonary acoustic transmission measurements. Med Biol Eng Comput (2002) 1.00

Indwelling small pleural catheter needle thoracentesis in the management of large pleural effusions. Chest (1997) 0.99

Desquamative interstitial pneumonia following long-term nitrofurantoin therapy. Am J Med (1976) 0.96

Effects of corticosteroids in the treatment of patients with gastric aspiration. Am J Med (1977) 0.96

Incidence of aspiration in tracheally intubated adults. Heart Lung (1987) 0.93

Laryngeal edema. An experimental study. Ann Otol Rhinol Laryngol (1970) 0.93

Technology under Medicare diagnosis-related groups prospective payment. Implications for medical intensive care. Chest (1985) 0.92

Why new definitions of sepsis and organ failure are needed. Am J Med (1993) 0.92

The septic syndrome. Definition and clinical implications. Crit Care Clin (1989) 0.92

A piece of my mind. Maumee: my Walden pond. JAMA (1996) 0.91

Sepsis and controlled clinical trials: the odyssey continues. Crit Care Med (1995) 0.91

Comparison of students' encounters with patients in university and community hospitals. J Med Educ (1986) 0.91

Long-term outcomes for elderly survivors of prolonged ventilator assistance. Chest (1989) 0.90

The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J Rheumatol (1995) 0.89

Prevention of pulmonary emboli in a respiratory intensive care unit: efficacy of low-dose heparin. Chest (1981) 0.89

Monoclonal antibodies to endotoxin. New allies against sepsis? JAMA (1991) 0.88

Immunoglobulin G-induced single ionic channels in human alveolar macrophage membranes. J Clin Invest (1985) 0.88

Helium-oxygen mixtures during bronchoscopy. Crit Care Med (1980) 0.88

Mechanical ventilation in respiratory failure. Med Clin North Am (1983) 0.87

The ARDS lung. New insights from computed tomography. JAMA (1993) 0.87

Noninvasive respiratory care unit. A cost effective solution for the future. Chest (1988) 0.87

Nitric oxide in the pathogenesis of sepsis. Infect Dis Clin North Am (1999) 0.87

To SIRS with love. Crit Care Med (1998) 0.86

Thrombotic thrombocytopenic purpura in carbon monoxide poisoning. Report of a case. Arch Intern Med (1980) 0.85

Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. Am Rev Respir Dis (1988) 0.85

Determination of cardiac output in critically ill patients by dual beam Doppler echocardiography. J Am Coll Cardiol (1989) 0.85

Economics of mechanical ventilation. Clin Chest Med (1988) 0.84

Element content of intracochlear fluids, outer hair cells, and stria vascularis as determined by energy-dispersive roentgen ray analysis. Otolaryngol Head Neck Surg (1979) (1980) 0.84

Important new findings in sepsis. JAMA (1997) 0.84

Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1993) 0.84

Treatment of adult respiratory distress syndrome with diuretics, dialysis, and positive end-expiratory pressure. Crit Care Med (1978) 0.84

Effect of cigarette smoke on human serum trypsin inhibitory capacity and antitrypsin concentration. Am Rev Respir Dis (1982) 0.84

Extraglandular Warthin's tumors. Laryngoscope (1985) 0.84

Laryngopyocele. Laryngoscope (1973) 0.84

Physiologic effects of oral bronchodilators during rest and exercise in chronic obstructive pulmonary disease. Chest (1983) 0.84

Contamination of a fiberoptic bronchoscope with Proteus species. Am Rev Respir Dis (1977) 0.83

Treatment of acute exacerbations in chronic obstructive pulmonary disease. Med Clin North Am (1990) 0.83

New creations? Hastings Cent Rep (1991) 0.83

Low dose ibuprofen reverses the hemodynamic alterations of canine endotoxin shock. Crit Care Med (1988) 0.83

Flexible fiberoptic laryngobronchoscopy. Laryngoscope (1974) 0.82

Non-simultaneous Interaction of exposure to noise and kanamycin intoxication in the chinchilla. Am J Otolaryngol (1983) 0.82

Lymphocyte subpopulations of blood and alveolar lavage in blastomycosis. Chest (1985) 0.82

Effects of ibuprofen on neutrophil function and acute lung injury in canine endotoxin shock. Crit Care Med (1988) 0.81

Ultrastructural correlates of selective outer hair cell destruction following kanamycin intoxication in the chinchilla. Hear Res (1980) 0.81

Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med (1991) 0.81

Hepatic dysfunction in the adult respiratory distress syndrome. Chest (1989) 0.81

Differential effects of tumor necrosis factor-alpha on the expression of fibronectin and collagen genes in cultured bovine endothelial cells. Cell Mol Biol Res (1995) 0.81

Potentiation of kanamycin ototoxicity by a history of noise exposure. Otolaryngology (1979) 0.81